Newsletter | January 26, 2022

01.26.22 -- Navigating To The Clinic And Beyond: Cell & Gene Therapy

 
The Raw Material Hurdle: Plasmids For Viral Vector-Based Gene Therapies
 

The success of using viral vectors to deliver a molecular payload into a cell or replace defective genes with functional ones is an inflection point in the future of modern medicine.

Technology Integrators In Cell And Gene Therapy: Powering Innovation
 

Accelerated clinical trial timelines for advanced therapeutics are on the rise. With fast-track status designations, it is increasingly critical for innovators to have efficient and scalable production processes.

Navigating The Path To The Clinic And Beyond For Gene Therapies
 

A gene therapy’s path from the research lab to the clinic and, ultimately, the market requires manufacturing processes that will meet the regulatory requirements and logistics to get therapies to clinical trial sites.

Radiance Label-Free Monitoring Of AAV Transfection In HEK293 Cells
 

LumaCyte’s Radiance® instrument has the potential to improve the characterization of cell-based AAV transfection and production, improving the efficiency and accuracy of both processes and shortening development time.